{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-045936","form_type":"8-K","ticker":"EPC","cik":"0001096752","company_name":"EDGEWELL PERSONAL CARE Co","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.657707+00:00","generated_at":"2026-05-30T03:16:06.961327+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Edgewell Q4 net sales down 3.1%, FY adj. EPS $3.05 (+18%), FY25 outlook 1-3% organic growth","bullets":["Q4 net sales $517.6M (-3.1% YoY); FY net sales $2,253.7M (+0.1% YoY); organic net sales FY +0.2%.","GAAP diluted EPS $0.17 (Q4) and $1.97 (FY); adjusted EPS $0.72 (Q4) and $3.05 (FY, +18% YoY).","Returned $90M to shareholders via $59M buybacks and $31M dividends in FY2024; declared Q4 dividend $0.15/share.","Fiscal 2025 outlook: organic net sales growth 1-3%; adjusted EPS growth ~7% (13% constant currency) at midpoint.","Ended Q4 with $209M cash, $386M revolver, net debt leverage 3.1x."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-045936","json":"https://secwatch.observer/filing/0001628280-24-045936.json","markdown":"https://secwatch.observer/filing/0001628280-24-045936.md","text":"https://secwatch.observer/filing/0001628280-24-045936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096752/000162828024045936/0001628280-24-045936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096752/000162828024045936/epc-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:16:06.961327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}